GT Biopharma announces agreement with major pharma company for OXS-1550
GT Biopharma announced a Material Transfer Agreement between a Major Pharmaceutical Company and the Masonic Cancer Center, University of Minnesota. The Company will supply a formulation of their multibillion dollar, widely prescribed oncology drug, to be used in this study. July 19, 2018